Skip to content

DrugCheck 60740-6

by Express Diagnostic Int'l, Inc. 2 variants

DrugCheck 60740-6 is a Class II device made by Express Diagnostic Int'l, Inc., listed in FDA GUDID since 9 Mar 2026 (UDI-DI B2986074060), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB2986074060 UDI-DI Date9 Mar 2026ListedStatusListed GUDID: in commercial distribution

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
DrugCheck
Generic name
Multiple drugs of abuse IVD, kit, rapid ICT, clinical
Model / Ref / Catalog
60740-6
Primary DI / UDI-DI
B2986074060
FDA product code
LDJ, LCM, DJG, NGG, DIO, DKZ
GMDN term
Multiple drugs of abuse IVD, kit, rapid ICT, clinical
Device class
Class II
Regulation number
862.3870, 862.3650, 862.3610, 862.3250, 862.3100
GUDID distribution status
In Commercial Distribution

Other devices from Express Diagnostic Int'l, Inc.

See all devices from Express Diagnostic Int'l, Inc. →

Properties

  • Single use
  • Over-the-counter
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)